Shopping Cart 0
Cart Subtotal
USD 0

Acute Heart Failure Global Clinical Trials Review, H2, 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500

Details

Acute Heart Failure Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, Acute Heart Failure Global Clinical Trials Review, H2, 2019" provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Table Of Content

Scope

Table of Contents

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 21

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Clinical Trials by End Point Status 27

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials 32

Prominent Drugs 33

Latest Clinical Trials News on Acute Heart Failure 34

Nov 17, 2019: Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists 34

Nov 13, 2019: Lilly and Boehringer begin study of Jardiance in heart failure 34

Oct 25, 2019: Windtree Therapeutics provides business update on istaroxime 35

Clinical Trial Profile Snapshots 36

Appendix 186

Abbreviations 186

Definitions 186

Research Methodology 187

Secondary Research 187

About GlobalData 188

Contact Us 188

Source 189


List Of Figure

List of Figures

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15

Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 17

Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 21

Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22

Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23

Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24

Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25

Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019* 27

Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 28

Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 29

Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30

Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 32

Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 33

GlobalData Methodology 187


List Of Table

List of Tables

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2019* 8

Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10

Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15

Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 18

Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 21

Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22

Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23

Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2019* 24

Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25

Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019* 27

Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 28

Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 29

Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31

Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 32

Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Novartis AG

Cytokinetics Inc

Capricor Therapeutics Inc

Abbott Laboratories

Bristol-Myers Squibb Co

Cardiorentis AG

Celerion Inc

Otsuka Holdings Co Ltd

Theravance Biopharma Inc

Amgen Inc

Company Profile

Company Profile Title

Acute Heart Failure Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, Acute Heart Failure Global Clinical Trials Review, H2, 2019" provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 21

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Clinical Trials by End Point Status 27

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials 32

Prominent Drugs 33

Latest Clinical Trials News on Acute Heart Failure 34

Nov 17, 2019: Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists 34

Nov 13, 2019: Lilly and Boehringer begin study of Jardiance in heart failure 34

Oct 25, 2019: Windtree Therapeutics provides business update on istaroxime 35

Clinical Trial Profile Snapshots 36

Appendix 186

Abbreviations 186

Definitions 186

Research Methodology 187

Secondary Research 187

About GlobalData 188

Contact Us 188

Source 189


List Of Figure

List of Figures

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15

Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 17

Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 21

Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22

Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23

Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24

Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25

Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019* 27

Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 28

Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 29

Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30

Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 32

Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 33

GlobalData Methodology 187


List Of Table

List of Tables

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2019* 8

Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10

Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15

Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 18

Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 21

Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22

Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23

Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2019* 24

Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25

Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019* 27

Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 28

Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 29

Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31

Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 32

Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Novartis AG

Cytokinetics Inc

Capricor Therapeutics Inc

Abbott Laboratories

Bristol-Myers Squibb Co

Cardiorentis AG

Celerion Inc

Otsuka Holdings Co Ltd

Theravance Biopharma Inc

Amgen Inc